Ezetimibe

CAS 163222-33-1 23 API suppliersSmall Molecule

Overview

Ezetimibe is used to reduce the amount of cholesterol and related sterols absorbed in the small intestine, which helps lower blood cholesterol levels. It is often combined with statins to further reduce cholesterol levels in hyperlipidemic patients.

API suppliers (23)

Suppliers of Ezetimibe evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India14China4Netherlands1

Country recorded for 19 of 23 suppliers.

12 of 23 hold a GMP certificate on record in the EU or UK registers

Patent & exclusivity (US)

Per the FDA Orange Book (13 approved US products), the latest listed US patent on Ezetimibe expires 30 Apr 2026. Generic API sourcing typically opens up once these lapse.

Therapeutic areas

Cardiovascular SystemMetabolic Disorders
Verified Supplier Partner

Do you supply Ezetimibe? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.